Article

OIG Expects Tighter Control on Compounded Drugs in CMS-Approved Hospitals

OIG recommends training for inspectors and amending contracts with stand-alone pharmacies to ensure improved quality and safety.

More than 2 years after drugs contaminated with a virulent fungus killed 64 patients and caused related illnesses in another 687, Medicare-approved hospital accreditors still don't properly oversee contracts hospitals have with compounding pharmacies to assure these drugs are safe, according to an Office of Inspector General report.

It recommends CMS consider requiring 55 practices to use accreditors to oversee compounded sterile preparations.

Link to the complete article on Medpage Today: http://bit.ly/1uY91MX

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
Related Content
The White House | Image credit: Maksym Yemelyanov - stock.adobe.com
April 16th 2025

Trump Signs Executive Order to Lower Drug Prices

Pearl Steinzor
The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
"Medicare Advantage" written on notepad | Image Credit: dizain - stock.adobe.com
April 7th 2025

Differential Coding Inflated Medicare Advantage Payments by $33 Billion in 2021, Study Finds

Brooke McCormick
In 2021, UnitedHealth Group received 42% of the $33 billion in additional Medicare Advantage payments from differential coding.
managed care cast logo
January 28th 2025

The Evolving Annual Wellness Visit

Laura Joszt, MA Christopher Wheelock, MD
The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early intervention.
AJMC
April 4th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

Galen Shearn-Nance, BS Rishi R. Sachdev, BS Long Vu, MS Weichuan Dong, PhD Alberto J. Montero, MD, MBA Siran M. Koroukian, PhD Johnie Rose, MD, PhD
This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
AJMC
April 2nd 2025

Prior Authorizations and the Adverse Impact on Continuity of Care

Jay S. Pickern, DBA
Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo